Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Akari Therapeutics (AKTX)

$1.93 0.04 (2.03%)

19:13 EST AKTX Stock Quote Delayed 15 Minutes

Volume:

Previous Close $1.93

Market Cap 29.45M

PE Ratio -

EPS -

Volume (Avg. Vol.) 71,000

Day's Range 1.85 - 1.94

52-Week Range 1.61 - 9.20

Dividend & Yield N/A (N/A)

AKTX Stock Predictions, Articles, and Akari Therapeutics News

From InvestorPlace
From the Web

Biopharma News: Why Akari Therapeutics (AKTX) Stock Is Soaring Today

By William White, InvestorPlace Writer Aug 14, 2019

Some recent biopharma news concerning Akari Therapeutics getting Fast Track approval from the FDA has AKTX stock flying high on Wednesday.

3 Stocks to Watch on Friday: BlackBerry Ltd (BBRY), Akari Therapeutics PLC (ADR) (AKTX) and Voxeljet AG (ADR) (VJET)

By Karl Utermohlen, InvestorPlace Writer Mar 31, 2017

BlackBerry (BBRY) and VoxelJet (VJET) were moving Friday on earnings, while Akari Therapeutics (AKTX) received some positive medical news.

The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion

From Benzinga Feb 21, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics...

Akari Therapeutics up 6% on encouraging nomacopan data

From Seeking Alpha Jan 27, 2020

Thinly traded nano cap Akari Therapeutics (AKTX +5.9%) is up on average volume in reaction to preclinical data on a long-acting version of lead drug nomacopan (PAS-nomacopan) that, it says, supports i

Akari Therapeutics (NASDAQ:AKTX) Will Have To Spend Its Cash Wisely

From Simply Wall St Jan 14, 2020

There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aktx/akari-therapeutics/news/akari-therapeutics-nasdaqaktx-will-have-to-spend-its-cash-wisely/">Read More...</a></div>

Best & Worst Performing Small Cap Stocks for January 10, 2020

From StockNews.com Jan 10, 2020

CPAH – CPAH leads the way today as the best performing small cap stock, closing up 295.96%.

Akari Therapeutics +7% premarket on initiating late-stage nomacopan trail in pediatric HSCT-TMA

From Seeking Alpha Dec 23, 2019

Akari Therapeutics (NASDAQ:AKTX) is up 7% premarket on announcing that the FDA IND is open for its multicenter Phase III study for the treatment of pediatric Hematopoietic Stem Cell Transplant-Relate

Do Directors Own Akari Therapeutics, Plc (NASDAQ:AKTX) Shares?

From Simply Wall St Dec 10, 2019

Every investor in Akari Therapeutics, Plc (NASDAQ:AKTX) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aktx/akari-therapeutics/news/do-directors-own-akari-therapeutics-plc-nasdaqaktx-shares/">Read More...</a></div>

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold